December 14-17, 2025
Marriott Marquis San Diego
Welcome to Antibody Engineering & Therapeutics 2025
Antibody Engineering & Therapeutics US is the leading event for antibody science and innovation, bringing together global experts for over 30 years. Join us to explore groundbreaking research, cutting-edge technologies, and therapeutic breakthroughs.
Network with top academic and industry leaders, engage in dynamic discussions, and build valuable connections. Be inspired by visionary keynotes and discover new ideas to drive your work forward. Don’t miss this opportunity to shape the future of antibody engineering!
Networking Breaks Not to Miss
Monday, 6:15-7:45 PM
Exhibit Hall Opening Night Reception
Why Essential: Prime networking time with beverages, appetizers, and poster viewing.
Strategic Value: End-of-day relaxed atmosphere perfect for meaningful conversations.
Attendee Mix: Full conference attendance including speakers, exhibitors, and delegates.
Tuesday, 6:15-7:15 PM
Exhibit Hall Networking Night Reception
Why Essential: Prime networking time with beverages, appetizers, and poster viewing
Strategic Value: End-of-day relaxed atmosphere perfect for meaningful conversations
Attendee Mix: Full conference attendance including speakers, exhibitors, and delegates
Daily, December 15-17
Groundbreaking Scientific Briefings
Concentrated updates on cutting-edge research and breakthrough discoveries
Never-before-seen data from leading industry and academic experts
Ensuring current knowledge of rapidly evolving antibody engineering trends
Daily, December 15-17
Technology Showcase Presentations
Why Essential: Unique format combining learning with networking during breaks
Strategic Value: Direct access to technology leaders and innovation showcases
Attendee Mix: Technology-focused professionals and potential collaborators
December 16, 9:45-10:30 AM
Morning Networking Break
Why Essential: Fresh energy, coffee, and exhibit hall access when attendees are most engaged
Strategic Value: Perfect timing between morning sessions to discuss presentations and make connections
Attendee Mix: Active conference participants ready to engage and collaborate
Daily- December 15-17
Networking Breaks
Why Essential: Connect with industry peers over refreshments and light bites throughout the event, from the Grand Opening of the Poster/Exhibit Hall to dedicated networking sessions and lunch breaks designed to foster meaningful professional connections. Last major networking opportunity before conference conclusion
Strategic Value: Exchange contact information and solidify connections made throughout the event
Attendee Mix: Committed attendees staying through final day – often the most engaged professionals
Not-to-Miss Sessions
AI-driven Design of Gated Cell Engagers
Why Critical: Cutting-edge intersection of AI and antibody engineering from industry leader
Impact: Represents future direction of the field with practical applications
Peyton Greenside, Ph.D., CEO,
BigHat Biosciences
De Novo Design of Hundreds of Functional GPCR-targeting Antibodies
Why Critical: Breakthrough in computational antibody design with therapeutic-grade results
Impact: Revolutionary approach achieving single-digit nM to picomolar affinities
Surge Biswas, Ph.D., Co-founder & CEO,
Nabla Bio
Results of the AIntibody Competition
Why Critical: Industry-wide benchmarking of AI methods in antibody discovery
Impact: Provides comparative insights into AI versus experimental methods
Andrew Bradbury, M.D., Ph.D.,
Chief Scientific Officer,
Specifica
AI-driven Design of Gated Cell Engagers
Why Critical: Cutting-edge intersection of AI and antibody engineering from industry leader
Impact: Represents future direction of the field with practical applications
Peyton Greenside, Ph.D., CEO,
BigHat Biosciences
De Novo Design of Hundreds of Functional GPCR-targeting Antibodies
Why Critical: Breakthrough in computational antibody design with therapeutic-grade results
Impact: Revolutionary approach achieving single-digit nM to picomolar affinities
Surge Biswas, Ph.D., Co-founder & CEO,
Nabla Bio
Results of the AIntibody Competition
Why Critical: Industry-wide benchmarking of AI methods in antibody discovery
Impact: Provides comparative insights into AI versus experimental methods
Andrew Bradbury, M.D., Ph.D.,
Chief Scientific Officer,
Specifica
Networking Events
Full-Day Training Course: Comprehensive Overview of Antibody Engineering
Value Add: Includes free admission to afternoon workshops AND opportunity to present a free poster during main conference.
Target Audience: Early career scientists, professionals transitioning into antibody therapeutics, or those wanting comprehensive background.
Afternoon Sessions: Pre-Conference Workshops
Full-Day Training Course: Comprehensive Overview of Antibody Engineering
Value Add: Includes free admission to afternoon workshops AND opportunity to present a free poster during main conference.
Target Audience: Early career scientists, professionals transitioning into antibody therapeutics, or those wanting comprehensive background.
Before You Arrive